Proceedings of the nineteenth annual symposium: advances in cardiovascular pharmacology: protocol design and methodology. the U.S. Regulatory Process. May 3, 4, 5, 2000, Washington, D.C.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D008133:Long QT Syndrome / Q000188:drug therapy; D012107:Research Design; D014481:United States; D014486:United States Food and Drug Administration
D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D002317:Cardiovascular Agents